GLP-1, Weight Loss Drugs, Ozempic, Obesity, NMDA Receptors, Metabolism & Brain Health

About the guest: Christoffer Clemmensen, PhD is scientist running the Metabolism & Molecular Pharmacology group at the University of Copenhagen in Denmark. His lab studies the biological basis of obesity & other metabolic disorders.
Episode summary: Nick and Dr. Clemmensen discuss: GLP-1 & gut hormones; obesity & metabolic disease; GLP-1 agonists and weight loss drugs (e.g. Ozempic); novel, dual-action weight loss drugs his lab has created; and more.
*This content is never meant to serve as medical advice.
All M&M content, including podcast episodes & written content, is available on Substack. I mainly respond to questions & comments on that channel:
[ mindandmatter.substack.com ]
If you enjoy M&M content and want to provide further support, read this:
[ mindandmatter.substack.com/p/... ]
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.
#Science #Podcast #Biology #Diet #Metabolism #Anthropology #Ethnography #Hunting #Neanderthals #Culture
0:00:00 Intro
0:02:25 Christoffer Clemmensen conversation

[@MindAndMatter]

All M&M content is available on Substack. Podcast, writing, free weekly newsletter:
[mindandmatter.substack.com]
If you enjoy M&M content and want to provide further support, read this:
[mindandmatter.substack.com/p/how-to-support-mind-and-matter?Fsearch%2Fsupport&]
Thanks!